Frontier Medicines picks up $67 mln
South San Francisco-based Frontier Medicines, a biopharmaceutical company, has raised $67 million in funding. Deerfield Management, Droia Oncology Ventures and MPM Capital led the round.
25 June 2019•1 min read
South San Francisco-based Frontier Medicines, a biopharmaceutical company, has raised $67 million in funding. Deerfield Management, Droia Oncology Ventures and MPM Capital led the round.
